{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:10:25Z","timestamp":1772791825011,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":1306,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1038\/s41385-018-0025-4","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T11:36:49Z","timestamp":1527766609000},"page":"1230-1238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Epigallocatechin-3-gallate local pre-exposure application prevents SHIV rectal infection of macaques"],"prefix":"10.1016","volume":"11","author":[{"given":"J.B.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.H.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.D.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.H.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.C.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Q.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.Z.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/s41385-018-0025-4_bib1","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1084\/jem.20091579","article-title":"Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells","volume":"206","author":"Ceballos","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1038\/s41385-018-0025-4_bib2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2007.10.014","article-title":"Semen-derived amyloid fibrils drastically enhance HIV infection","volume":"131","author":"Munch","year":"2007","journal-title":"Cell"},{"key":"10.1038\/s41385-018-0025-4_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4508","article-title":"Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen","volume":"5","author":"Usmani","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1038\/s41385-018-0025-4_bib4","doi-asserted-by":"crossref","first-page":"262ra157","DOI":"10.1126\/scitranslmed.3009634","article-title":"Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides","volume":"6","author":"Zirafi","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1038\/s41385-018-0025-4_bib5","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1371\/journal.pmed.0050157","article-title":"Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel","volume":"5","author":"Cranage","year":"2008","journal-title":"PLoS Med."},{"key":"10.1038\/s41385-018-0025-4_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1126\/science.1099288","article-title":"Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5","volume":"306","author":"Lederman","year":"2004","journal-title":"Science"},{"key":"10.1038\/s41385-018-0025-4_bib7","doi-asserted-by":"crossref","first-page":"a007385","DOI":"10.1101\/cshperspect.a007385","article-title":"Microbicides: topical prevention against HIV","volume":"2","author":"Shattock","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1038\/s41385-018-0025-4_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/655661","article-title":"Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor","volume":"202","author":"Veazey","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1038\/s41385-018-0025-4_bib9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.1248707","article-title":"Long-acting integrase inhibitor protects macaques from intrarectal simian\/human immunodeficiency virus","volume":"343","author":"Andrews","year":"2014","journal-title":"Science"},{"key":"10.1038\/s41385-018-0025-4_bib10","doi-asserted-by":"crossref","first-page":"270ra274","DOI":"10.1126\/scitranslmed.3010298","article-title":"A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge","volume":"7","author":"Andrews","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1038\/s41385-018-0025-4_bib11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/OLQ.0b013e318195c31a","article-title":"A summary of preclinical topical microbicide rectal safety and efficacy evaluations in a pigtailed macaque model","volume":"36","author":"Patton","year":"2009","journal-title":"Sex. Transm. Dis."},{"key":"10.1038\/s41385-018-0025-4_bib12","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/bph.12009","article-title":"Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea","volume":"168","author":"Steinmann","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1038\/s41385-018-0025-4_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaci.2008.12.024","article-title":"Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy","volume":"123","author":"Nance","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/s41385-018-0025-4_bib14","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1242\/bio.010215","article-title":"Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils","volume":"4","author":"Castellano","year":"2015","journal-title":"Biol. Open"},{"key":"10.1038\/s41385-018-0025-4_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/1742-6405-9-2","article-title":"Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG","volume":"9","author":"Hartjen","year":"2012","journal-title":"AIDS Res. Ther."},{"key":"10.1038\/s41385-018-0025-4_bib16","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/00002030-200204120-00020","article-title":"Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent","volume":"16","author":"Fassina","year":"2002","journal-title":"AIDS"},{"key":"10.1038\/s41385-018-0025-4_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0166-3542(01)00189-9","article-title":"Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1)","volume":"53","author":"Yamaguchi","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1038\/s41385-018-0025-4_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3851\/IMP1774","article-title":"Epigallocatechin gallate inhibits the HIV reverse transcription step","volume":"21","author":"Li","year":"2011","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1038\/s41385-018-0025-4_bib19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.clim.2010.08.007","article-title":"The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors","volume":"137","author":"Jiang","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1038\/s41385-018-0025-4_bib20","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0091-6749(03)02007-4","article-title":"Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding","volume":"112","author":"Kawai","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/s41385-018-0025-4_bib21","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jaci.2006.08.016","article-title":"Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy","volume":"118","author":"Williamson","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/s41385-018-0025-4_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/QAI.0000000000001361","article-title":"Epigallocatechin gallate inhibits macaque SEVI-mediated enhancement of SIV or SHIV infection","volume":"75","author":"Zhou","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1038\/s41385-018-0025-4_bib23","doi-asserted-by":"crossref","first-page":"AB209","DOI":"10.1016\/j.jaci.2016.12.679","article-title":"Translational medicine in HIV-1 infection: preclinical and clinical development of the green tea catechin, Epigallocatechin Gallate, as therapy and immunological signatures","volume":"139","author":"Nance","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1038\/s41385-018-0025-4_bib24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2105\/AJPH.2009.181883","article-title":"Unprotected anal intercourse and sexually transmitted diseases in high-risk heterosexual women","volume":"101","author":"Jenness","year":"2011","journal-title":"Am. J. Public Health"},{"key":"10.1038\/s41385-018-0025-4_bib25","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/blood-2010-12-325860","article-title":"Barriers to mucosal transmission of immunodeficiency viruses","volume":"118","author":"Keele","year":"2011","journal-title":"Blood"},{"key":"10.1038\/s41385-018-0025-4_bib26","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ije\/dyq057","article-title":"HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention","volume":"39","author":"Baggaley","year":"2010","journal-title":"Int. J. Epidemiol."},{"key":"10.1038\/s41385-018-0025-4_bib27","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1021\/jp0550762","article-title":"How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors","volume":"110","author":"Hamza","year":"2006","journal-title":"J. Phys. Chem. B"},{"key":"10.1038\/s41385-018-0025-4_bib28","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.1073\/pnas.0811827106","article-title":"The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection","volume":"106","author":"Hauber","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1038\/s41385-018-0025-4_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/JVI.01366-08","article-title":"The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection","volume":"83","author":"Roan","year":"2009","journal-title":"J. Virol."},{"key":"10.1038\/s41385-018-0025-4_bib30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tim.2015.05.001","article-title":"Improving preclinical models of HIV microbicide efficacy","volume":"23","author":"Roan","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1038\/s41385-018-0025-4_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-6-150","article-title":"Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides","volume":"6","author":"Neurath","year":"2006","journal-title":"BMC Infect. Dis."},{"key":"10.1038\/s41385-018-0025-4_bib32","first-page":"3312","article-title":"Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals","volume":"9","author":"Chow","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1038\/s41385-018-0025-4_bib33","doi-asserted-by":"crossref","first-page":"3262S","DOI":"10.1093\/jn\/133.10.3262S","article-title":"Mechanisms of cancer prevention by tea constituents","volume":"133","author":"Lambert","year":"2003","journal-title":"J. Nutr."},{"key":"10.1038\/s41385-018-0025-4_bib34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/1940-6207.CAPR-11-0306","article-title":"Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities","volume":"5","author":"Nguyen","year":"2012","journal-title":"Cancer Prev. Res."},{"key":"10.1038\/s41385-018-0025-4_bib35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/147323000303100205","article-title":"A single ascending dose study of epigallocatechin gallate in healthy volunteers","volume":"31","author":"Ullmann","year":"2003","journal-title":"J. Int. Med. Res."},{"key":"10.1038\/s41385-018-0025-4_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/0975-8844.99891","article-title":"Topical application of green tea polyphenol (\u2212)-Epigallocatechin-3-gallate (EGCG) for prevention of recurrent oral neoplastic lesions","volume":"4","author":"Yoon","year":"2012","journal-title":"J. Orofac. Sci."},{"key":"10.1038\/s41385-018-0025-4_bib37","first-page":"6","article-title":"Polyphenon E 10% ointment: a guide to its use in the treatment of external genital and perianal warts","volume":"28","author":"Lyseng-Williamson","year":"2012","journal-title":"Drugs Ther. Perspect."},{"key":"10.1038\/s41385-018-0025-4_bib38","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1365-2133.2008.08520.x","article-title":"Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial","volume":"158","author":"Stockfleth","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1038\/s41385-018-0025-4_bib39","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1002\/mnfr.200800169","article-title":"Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans","volume":"53","author":"Stalmach","year":"2009","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1038\/s41385-018-0025-4_bib40","first-page":"83","article-title":"Investigating the stability of EGCg in aqueous media","volume":"20","author":"Zhou","year":"2003","journal-title":"Curr. Sep."},{"key":"10.1038\/s41385-018-0025-4_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2014.10.008","article-title":"Toll-like receptor 3 signaling inhibits simian immunodeficiency virus replication in macrophages from rhesus macaques","volume":"112","author":"Sang","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1038\/s41385-018-0025-4_bib42","doi-asserted-by":"crossref","first-page":"9432","DOI":"10.1128\/JVI.00852-12","article-title":"Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N","volume":"86","author":"Shakirzyanova","year":"2012","journal-title":"J. Virol."},{"key":"10.1038\/s41385-018-0025-4_bib43","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.284.5415.816","article-title":"Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs","volume":"284","author":"Harouse","year":"1999","journal-title":"Science"},{"key":"10.1038\/s41385-018-0025-4_bib44","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1038\/s41385-018-0025-4_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-10-9","article-title":"Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques","volume":"10","author":"Ren","year":"2013","journal-title":"Retrovirology"},{"key":"10.1038\/s41385-018-0025-4_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-11-22","article-title":"The number and genetic relatedness of transmitted\/founder virus impact clinical outcome in vaginal R5 SHIVSF162P3N infection","volume":"11","author":"Tsai","year":"2014","journal-title":"Retrovirology"},{"issue":"6","key":"10.1038\/s41385-018-0025-4_bib47","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.20041196","article-title":"Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+T Lymphocytes from Effector Sites in the Gastrointestinal Tract","volume":"200","author":"Mehandru","year":"2004","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1038\/s41385-018-0025-4_bib48","doi-asserted-by":"crossref","unstructured":"Kim, J. J., Shajib, M. S., Manocha, M. M. & Khan, W. I. Investigating intestinal inflammation in DSS-induced model of IBD. J. Vis. Exp. e3678 (2012).","DOI":"10.3791\/3678-v"},{"key":"10.1038\/s41385-018-0025-4_bib49","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00007435-199911000-00005","article-title":"Safety and toxicity of nonoxynol-9 gel as a rectal microbicide","volume":"26","author":"Tabet","year":"1999","journal-title":"Sex. Transm. Dis."},{"key":"10.1038\/s41385-018-0025-4_bib50","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1365-2249.1999.00878.x","article-title":"Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice","volume":"116","author":"Obermeier","year":"1999","journal-title":"Clin. Exp. Immunol."}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41385-018-0025-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41385-018-0025-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922004792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922004792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41385-018-0025-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:14:19Z","timestamp":1761830059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021922004792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1933021922004792"],"URL":"https:\/\/doi.org\/10.1038\/s41385-018-0025-4","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigallocatechin-3-gallate local pre-exposure application prevents SHIV rectal infection of macaques","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41385-018-0025-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 \u00a9 Society for Mucosal Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}